Mark O'Connor

Director, Manufacturing Sciences & Technology
Mark is a site MSAT Director in GSK, with over 11+ years of experience in pharmaceutical manufacturing and development roles. He is accountable for nurturing the talent, the culture and capabilities of a an MSAT organisation who are accountable for new product introductions, technical standards, subject matter expertise and excellent technical execution to meet patient supply. Mark is a leader who is passionate about the interface of people, lean and innovative technologies to shape the future of how to develop and manufacture life changing medicines. He a Six Sigma certified Black Belt, with a passion for coaching, team effectiveness, problem solving, and process improvement. Previously, Mark was accountable for building the team, the culture and capabilities to transition of two advanced aseptic syringe filling and assembly assets from the global engineering function to beneficial operations in AstraZeneca, ensuring the operational readiness, cGMP compliance and performance of the assets to meet patient supply. Prior to that he was a Global Technical Manager for Validation Sciences, where he was the global lead for Continued Process Verification (CPV) and the Process Intelligence data strategy. He also authored the cross-functional quality standards and guidelines for Process Validation lifecycle and chaired the global network of CPV data analysts from AstraZeneca's network of production facilities. Mark has an MSc in Analytical Science from Kings College London and a BSc in Chemistry from National University of Ireland, Galway. He is an active member and volunteer of ISPE, and has delivered podium presentations, contributed to guidelines and co-chaired technical committees, as well as being on the ISPE annual meeting organising committee.